LPL Financial »

Compass Therapeutics shares owned by LPL Financial

Quarter-by-quarter ownership of Compass Therapeutics (CMPX) shares owned by LPL Financial from 13F filings

Historical chart of LPL Financial investment in Compass Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Compass Therapeutics held by LPL Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Therapeutics by LPL Financial

Quarter filed Position value Share count Share price at filing
2024-09-30 $92k 50k 1.84
2024-06-30 $50k 50k 1.00

More positions owned by LPL Financial

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Vanguard Index Fds Total Stk Mkt (VTI)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Us Treas Bd Etf (GOVT)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Amazon (AMZN)

View all positions for LPL Financial

Top funds holding Compass Therapeutics

OrbiMed Advisors
Blackstone Group
BlackRock
BlackRock
Rock Springs Capital Management
Henderson Group
MPM Oncology Impact Management
Vanguard Group
Blue Owl Capital Holdings
Geode Capital Management
Cormorant Asset Management
State Street Corporation
Tang Capital Management
Baker Bros. Advisors
Northern Trust

View all funds holding Compass Therapeutics